Literature DB >> 6511134

Effect of gastric pH on antidotal efficacy of activated charcoal in man.

K T Olkkola, P J Neuvonen.   

Abstract

Environmental pH is important for the adsorption capacity of activated charcoal: in our experiments the unadsorbed fractions of aspirin and disopyramide were increased by 10-20-fold as the pH was altered from 1.2 to 7.0 or vice versa. In order to study the effect of pH in vivo, six subjects were given 500 mg aspirin, 200 mg disopyramide and 200 mg tolfenamic acid on an empty stomach with 20 ml of 8.5% magnesium hydroxide or without it. A small dose of charcoal, 2.5 g, administered immediately after the drugs, reduced the absorption of aspirin by 30-40%, whereas the absorption of disopyramide and tolfenamic acid was reduced by 70-80%. The inhibition of absorption was irrespective of whether the drugs were taken with the antacid or without it. Thus, in vivo other factors than the gastric pH must be more important in controlling the adsorption to activated charcoal. Accordingly, the simultaneous administration of antacids cannot be recommended to enhance the adsorptive capacity of charcoal in humans.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6511134

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  3 in total

1.  Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males.

Authors:  H Stass; D Kubitza; J-G Möller; H Delesen
Journal:  Br J Clin Pharmacol       Date:  2005-05       Impact factor: 4.335

Review 2.  Toxic effects of nonsteroidal anti-inflammatory drugs in overdose. An overview of recent evidence on clinical effects and dose-response relationships.

Authors:  S C Smolinske; A H Hall; S A Vandenberg; D G Spoerke; P V McBride
Journal:  Drug Saf       Date:  1990 Jul-Aug       Impact factor: 5.606

Review 3.  Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses.

Authors:  P J Neuvonen; K T Olkkola
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jan-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.